Brussels, 23/05/2013 (Agence Europe) - On 21 May, the French national agency for safety of medicines (ANSM) decided to suspend the marketing authorisation for the Diane 35 contraceptive pill, despite the contrary recommendation from the European Medicines Agency (EMA). The latter considers that the “benefits of Diane 35 and its generics compensate for the risks to certain kinds of patients” and therefore this kind of medicine should not be withdrawn from the European market. The Diane 35...